Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Prenatal Secondhand Cigarette Smoke Promotes Th2 Polarization and Impairs Goblet Cell Differentiation and Airway Mucus Formation

Shashi P. Singh, Sravanthi Gundavarapu, Juan C. Peña-Philippides, Jules Rir-sima-ah, Neerad C. Mishra, Julie A. Wilder, Raymond J. Langley, Kevin R. Smith and Mohan L. Sopori
J Immunol November 1, 2011, 187 (9) 4542-4552; DOI: https://doi.org/10.4049/jimmunol.1101567
Shashi P. Singh
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sravanthi Gundavarapu
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan C. Peña-Philippides
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jules Rir-sima-ah
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neerad C. Mishra
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie A. Wilder
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond J. Langley
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin R. Smith
†Chronic Obstructive Pulmonary Disease Program, Lovelace Respiratory Research Institute, Albuquerque, NM 87108
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohan L. Sopori
*Respiratory Immunology Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Abstract

Parental, particularly maternal, smoking increases the risk for childhood allergic asthma and infection. Similarly, in a murine allergic asthma model, prenatal plus early postnatal exposure to secondhand cigarette smoke (SS) exacerbates airways hyperreactivity and Th2 responses in the lung. However, the mechanism and contribution of prenatal versus early postnatal SS exposure on allergic asthma remain unresolved. To identify the effects of prenatal and/or early postnatal SS on allergic asthma, BALB/c dams and their offspring were exposed gestationally and/or 8–10 wk postbirth to filtered air or SS. Prenatal, but not postnatal, SS strongly increased methacholine and allergen (Aspergillus)-induced airway resistance, Th2 cytokine levels, and atopy and activated the Th2-polarizing pathway GATA3/Lck/ERK1/2/STAT6. Either prenatal and/or early postnatal SS downregulated the Th1-specific transcription factor T-bet and, surprisingly, despite high levels of IL-4/IL-13, dramatically blocked the allergen-induced mucous cell metaplasia, airway mucus formation, and the expression of mucus-related genes/proteins: Muc5ac, γ-aminobutyric acid A receptors, and SAM pointed domain-containing Ets-like factor. Given that SS/nicotine exposure of normal adult mice promotes mucus formation, the results suggested that fetal and neonatal lung are highly sensitive to cigarette smoke. Thus, although the gestational SS promotes Th2 polarization/allergic asthma, it may also impair and/or delay the development of fetal and neonatal lung, affecting mucociliary clearance and Th1 responses. Together, this may explain the increased susceptibility of children from smoking parents to allergic asthma and childhood respiratory infections.

Asthma is a heterogenous disease (1), characterized by airways hyperreactivity (AHR), episodic wheezing, airway inflammation, and mucus secretion (2). Allergic asthma is the most common form of asthma in children. It starts in early life and is associated with AHR, airway inflammation, and atopy (3). Th2 polarization, the hallmark of asthma, is seen in human (3) and animal models of allergic asthma (4, 5).

Deleterious effects of tobacco smoke on human health are well established (6, 7), and increasing epidemiological evidence suggests that environmental factors such as secondhand tobacco smoke and polycyclic aromatic hydrocarbons are important contributors in the development of childhood asthma (8–10). Exposure to cigarette smoke during fetal development and in the early years of a child’s life is a strong risk factor for pulmonary dysfunction, including asthma and chronic obstructive pulmonary disease (COPD) (11). Parental smoking, particularly maternal smoking, is strongly linked to allergic asthma and infection in children (12–14). Similarly, mice exposed to secondhand cigarette smoke (SS) during early postnatal life develop exacerbated respiratory infections (15). However, results from epidemiological studies are equivocal in identifying the developmental stage at which the fetus and child are vulnerable to the proasthmatic effects of maternal smoking. Thus, a link between maternal smoking and childhood asthma has been suggested when both parents were asthmatic (16) or smoke exposure occurred during early childhood (17), during both prenatal and early postnatal life (18, 19), during pregnancy only (20–22), or during prenatal or early postnatal life (23, 24). A possible explanation for these diverse results is that asthma is a heterogenous disease (1) and, in humans, it is difficult to control all of the confounders of childhood asthma, such as genetics, birth weight, β2-adrenergic receptor, breastfeeding, and air pollution.

To simulate maternal exposure to cigarette smoke in animal models of allergic asthma, we and other investigators showed that prenatal plus early postnatal exposure to mainstream or SS exacerbates allergic asthma (5, 25, 26); however, as in humans, individual contributions of prenatal and postnatal smoke exposure on the development of early allergic asthma is not clearly resolved. Moreover, the potential mechanism by which cigarette smoke exposure promotes allergic asthma is not known. In this study, we used an established mouse model of allergic asthma to isolate the effects of gestational and early postnatal SS exposure on the development of allergic asthma. To our knowledge, we show for the first time that gestational exposure to SS is by far the overwhelming risk factor for exacerbated AHR, Th2 polarization, and atopy and is associated with activation of GATA3/Lck/ERK1/2/STAT6. Surprisingly, unlike the promucoid effects of cigarette smoke/nicotine in adult humans and animals (27–29), both prenatal and early postnatal exposure to SS suppressed the various parameters of airway mucus response.

Materials and Methods

Animals

Pathogen-free BALB/c mice from the Frederick Cancer Research Facility (Frederick, MD) were housed in shoebox-type plastic cages with hardwood chip bedding and conditioned to whole-body exposure in exposure chambers (H1000; Hazleton Systems) for 2 wk before exposure to SS for breeding (5). The chamber temperature was maintained at 26 ± 2°C, and lights were set to a 12-h on/off cycle. Food and water were provided ad libitum. The Animal Care and Use Committee of Lovelace Respiratory Research Institute approved all animal protocols.

Abs and reagents

All reagents, unless stated otherwise, were purchased from Sigma-Aldrich (St. Louis, MO).

Cigarette smoke generation and exposure

Mice were exposed to whole-body SS (smoke released from the burning end of a cigarette) or filtered air (FA) for 6 h/d, 7 d/wk, as described (5). Briefly, a smoking machine (AMESA Type 1300; AMESA Technologies, Geneva, Switzerland) generated two 70-cm3 puffs/min from a research cigarette (type 2R1; Tobacco and Health Research Institute, Lexington, KY), and the smoke was captured from the lit end of the cigarettes with a plastic manifold placed above it. This level (total particulate matter, 1.52 ± 0.41 mg/m3) of exposure simulates the conditions at which a pregnant woman would be exposed to environmental tobacco smoke for 3 h/d in a smoking bar (5). Adult (3−4-mo-old) male and female mice were separately acclimatized to SS or FA for 2 wk prior to mating. After ascertaining pregnancy by vaginal smear, pregnant mice were housed singly in plastic cages and continued to receive SS or FA until the pups were born. The mothers and pups continued to be exposed to either FA or SS starting from day 1 of birth until the pups were weaned at 3 wk of age, and the pups continued to be exposed to FA or SS postnatally until sacrifice between 8–10 wk of age. This led to four groups of experimental animals, receiving the following combination of prenatal/postnatal exposure: FA/FA, FA/SS, SS/FA, and SS/SS.

Sensitization with allergen

The allergen used in the study was a lyophilized culture filtrate preparation of Aspergillus fumigatus; the filtrates (kindly provided by Dr. John M. Routes, Department of Pediatrics, Children’s Hospital, Wisconsin Medical College, Milwaukee, WI) were stored at −70°C until use. Mice were immunized intratracheally (i.t.) with A. fumigatus (50 μg/0.1 ml endotoxin-free sterile saline or sterile saline alone) and subsequently challenged i.t. with the A. fumigatus extracts (100 μg/0.1 ml) three times at 5-d intervals (5).

Total serum IgE

Total serum IgE levels were determined on diluted (1:100) serum using a mouse-specific serum IgE ELISA kit (MD Bioproducts, St. Paul, MN), according to the manufacturer’s instructions. The sensitivity of the assay was <2.0 ng/ml; the cross-reactivity with IgG was <0.01%.

Airway resistance

Forty-eight hours after the last A. fumigatus or saline challenge, airway resistance (Rl) was measured by the FlexiVent system (SCIREQ, Montreal, Quebec, Canada), as described (5). The peak Rl response at the nebulized A. fumigatus (200 μg/ml) concentration and at each methacholine (MCh) concentration was used for data analysis.

Bronchoalveolar lavage fluid collection, cell differentials, and cytokine analysis

Established protocols were followed to obtain bronchoalveolar lavage fluid (BALF) from the animals (5). Briefly, mice were anesthetized and killed by exsanguination 48 h after the last A. fumigatus challenge. Before excision of the lungs, the trachea was surgically exposed, cannulated and, while the left lung lobe was tied off with a silk thread, the right lobe was lavaged twice with 1 ml sterile Ca2+/Mg2+-free PBS (pH 7.4). Aliquots were pooled from individual animals. Cell differentials and cytokine assays were performed, as described (5). Macrophage, neutrophil, lymphocyte, and eosinophil numbers were determined microscopically by counting ≥300 cells/sample. Lavage cytokines were assayed using the Mouse Cytokine MultiPlex ELISA kit (Biosource-Invitrogen, Camarillo, CA), according to the manufacturer’s directions. The sensitivity of the assay was <10 pg/ml.

Immunohistochemistry

For immunohistochemical detection of airway mucus, formaldehyde-fixed left lung sections (5 μm) were stained with Alcian blue–periodic acid-Schiff (AB-PAS), as described previously (28). By this procedure, the mucus-producing cells stained distinctive pink and were examined microscopically at 40× magnification.

Analysis of mucosubstances in lung airways

The volume of mucous cells and the density of mucosubstances (Vs) in the airway epithelium were quantitated by a semiautomatic image-analysis system (28), using the public domain National Institutes of Health Image program (http//rsb.info.nih.gov/nih.gov/nih-image). Morphometry was performed blinded, and the data were expressed as the mean ± SD Vs (nl/mm2 basal lamina).

SAM pointed domain-containing Ets-like factor staining

Paraffin-embedded lung tissue (5 μm) was deparaffinized and rehydrated by placing slides on a slide warmer at 56°C for 20 min, followed by three 10-min incubations in xylene and a series of alcohol washes, followed by PBS. Ag retrieval was performed by immersing the slides in 10 mM citrate buffer at 90°C for 15 min. Endogenous peroxidase quenching was done by placing the slides in 3% H2O2 in methanol for 15 min at room temperature (RT), washing (five times in PBS), and blocking with 10% goat serum for 2 h at RT. The slides were incubated overnight at 4°C with a guinea pig anti-mouse polyclonal SAM pointed domain-containing Ets-like factor (SPDEF) Ab (GP954; a generous gift from Dr. Jeffrey Whitsett, Cincinnati Children’s Hospital, Cincinnati, OH) at 1:2500 dilution. Slides were washed five times with buffer and incubated at RT for 30 min with a 1:200 dilution of a goat anti-guinea pig biotinylated IgG (catalog no. BA-1000; Vector Lab, Burlingame, CA). Slides were washed in PBS and incubated for 30 min in the Immunoperoxidase Kit (catalog no. PK-6100; Vector), per the manufacturer’s instructions. Slides were washed five times in buffer and incubated for 2 min at RT in peroxidase substrate (catalog no. SK-4100; Vector) without nickel. Slides were then counterstained with hematoxylin and dehydrated. Slides were examined at 40×; SPDEF stains brown.

Quantitative PCR

Total RNA was extracted from the frozen lung samples using TRI reagent (Molecular Research Center, Cincinnati, OH) and quantified per the manufacturer’s instructions. The lung expression of the airway mucin Muc5ac, the Th1 transcription factor T-bet, the Th2 transcription factor GATA3, and the housekeeping gene GAPDH was determined using primer/probe sets (Applied Biosystems, Foster City, CA). The relative expression (test mRNA/GAPDH) was calculated (5).

Western blot analysis

Lung tissues were homogenized in radioimmunoprecipitation assay buffer (20 mM Tris, 150 mM NaCl, 20 mM β-glyceryl-phosphate, 1% Triton X-100, 10 mM NaF, 5 mM EDTA, 1 mM Na3VO4) containing protease inhibitors (1 mM PMSF; 1 μg/ml each aprotinin, antipain, and leupeptin) at 4°C. Protein content and Western blot (WB) analysis were performed, as described (5). NF-κB (p65), GATA3, STAT5, STAT6, and Lck were determined by probing the blots with anti–phospho-NF-κB-p65 (Ser529, rabbit polyclonal; Abcam, San Francisco, CA), anti–phospho-GATA3 (Ser308, rabbit polyclonal; Abcam), anti–phospho-STAT5, (Tyr694/699, mouse monoclonal; Abcam), anti–phospho-STAT6 (Tyr641, rabbit polyclonal; Cell Signaling Technology, Danvers, MA), and anti–phospho-Lck (Tyr394, rabbit polyclonal; Cell Signaling Technology). The γ-aminobutyric acid A receptor (GABAAR) and T-bet expression was determined by probing the blot with anti-GABAAR (mouse monoclonal; Millipore, Temecula, CA) and anti–T-bet Ab (mouse monoclonal; Abcam). Blots were developed with ECL (Amersham Biosciences, U.K.) using x-ray photograph film.

Densitometry

The x-ray films of WBs were scanned and quantified with a GS-800 Calibrated Densitometer using Quantity-One software (Bio-Rad, Hercules, CA).

Data presentation and statistical analysis

All data were analyzed using Graph Pad Prism software 5.03 (GraphPad, San Diego, CA). One-way ANOVA was used to compare the mean between groups using the Tukey post hoc test, which compares all groups at 95% confidence intervals. Where needed, Bonferroni correction was also used for multiple comparisons. Results are presented as the mean ± SD; p values ≤ 0.05 were considered statistically significant.

Results

Prenatal, but not postnatal, exposure to SS increases AHR

We previously showed that prenatal plus perinatal exposure to SS increased Rl to MCh (5); however, individual contributions of prenatal and postnatal SS exposure on AHR were not addressed. Therefore, dams were exposed to SS or FA, as described in Materials and Methods; 17 d prior to sacrifice, four groups of animals (FA/FA, FA/SS, SS/FA, and SS/SS) were sensitized with A. fumigatus. Rl was determined in response to aerosolized MCh (Fig. 1A) or a predetermined optimal concentration of aerosolized A. fumigatus (200 μg/ml) (Fig. 1B). Results demonstrated that, compared with FA/FA, both MCh and A. fumigatus caused dramatic increases in the Rl in prenatally SS-exposed animal groups (SS/SS and SS/FA); however, the Rl values between FA/FA and FA/SS groups and between SS/SS and SS/FA groups were not significantly different, indicating that, unlike prenatal SS exposure, postnatal SS exposure does not affect RL significantly. MCh-induced changes in RL values of mice not sensitized to A. fumigatus indicated that, even in the absence of allergen, prenatally SS-exposed mice (SS/FA and SS/SS) were significantly more sensitive to MCh than FA/FA or FA/SS mice (Supplemental Fig. 1). Even the basal RL of prenatally SS-exposed mice was somewhat higher (statistically significant) than that of FA/FA or FA/SS mice. These results suggested that, although prenatal SS exposure strongly exacerbates MCh- and A. fumigatus-induced AHR, SS exposure during the early postnatal life had a relatively minor effect on this response. Moreover, in this model, changes in AHR reached the level that allowed Rl measurements in response to the allergen (A. fumigatus). RL measurements in non-A. fumigatus-sensitized mice indicated that prenatal exposure to SS exacerbated MCh-induced AHR; however, the degree of the response was considerably lower than in A. fumigatus-sensitized mice (Supplemental Fig. 1). Thus, prenatal SS exposure primes the lung for exacerbated AHR response.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Prenatal, but not postnatal, exposure to SS exacerbates airway reactivity, strongly upregulates allergen-induced Th2 cytokine expression, and increases total serum IgE levels. Lung resistance (RL: cm H2O s/ml) was measured using FlexiVent system in response to increasing doses of computer-controlled nebulized MCh (A) and a single nebulized dose (200 μg/ml) of A. fumigatus (B). Inset in A shows baseline differences between the groups in response to nebulized saline. Peak responses at each MCh concentration and response to A. fumigatus were used for data analysis. IL-4 (C) and IL-13 (D) levels were determined in BALF from A. fumigatus-sensitized mice by the Multiplex ELISA kit. E, Total IgE levels in the serum of A. fumigatus-sensitized mice were quantitated by using a mouse-specific IgE ELISA kit. All animals were sensitized with A. fumigatus, as described in Materials and Methods prior to RL determination. The results are representative of animal responses from two different sets of inhalation exposures. Data are expressed as mean ± SD (n = 5–7/group). *p ≤ 0.05, ***p ≤ 0.001.

Prenatal SS exposure induces a strong Th2 cytokine response in the lung

The Th2 cytokines, particularly IL-13 and IL-4, play an essential role in allergic asthma and Th2 polarization (30, 31); however, only AHR responses, and not Th2 responses, are ameliorated by the phosphodiesterase4-selective inhibitor rolipram. This suggested that AHR and Th2 responses are regulated by different mechanisms (5) and, therefore, it was possible that prenatal and early postnatal SS exposure might affect AHR and Th2 polarization differently. To ascertain this possibility, we determined the A. fumigatus-induced IL-4 and IL-13 production in four groups of mice: FA/FA, SS/FA, FA/SS, and SS/SS. Results presented in Figure 1C and 1D indicated that, compared with control mice (FA/FA), the early postnatal exposure to smoke (FA/SS) produced a relatively small, but significant, increase in the BALF levels of the Th2 cytokines IL-4 (Fig. 1C) and IL-13 (Fig. 1D) in response to A. fumigatus sensitization. However, these levels were much lower than those present in the BALF from prenatally SS-exposed animals (IL-4: 13.48 ± 3.74 and 6.30 ± 1.92, SS/FA and FA/SS, respectively; IL-13: 111.7 ± 19.82 and 34.58 ± 15.65 ng/ml, SS/FA and FA/SS, respectively). Compared with A. fumigatus-sensitized mice, the levels of IL-4 and IL-13 in nonsensitized mice were very low (Supplemental Fig. 2). These results suggested that prenatal exposure to SS is the predominant risk factor in driving the lung toward Th2 polarization. In contrast, the levels of IL-4, and IL-13 in mice without A. fumigatus challenges, did not reach statistical significance, indicating that the critical levels of these cytokines are achieved only after allergic sensitization.

Prenatal exposure to SS increases leukocytic infiltration in the lung after A. fumigatus sensitization

Elevated numbers of eosinophils and neutrophils in the lung are associated with allergic asthma (5). To determine whether pre- and/or postnatal exposure to SS differentially affected the leukocytic infiltration in the lung in response to an allergic challenge, A. fumigatus-sensitized FA/FA, FA/SS, SS/FA, and SS/SS mice were challenged i.t. with A. fumigatus extracts. The volume of BALF recovered was not significantly different among the groups. BALF cells were collected, cytospun, and stained to obtain the differential cell count. Prior to A. fumigatus sensitization, the total number of leukocytes in the BALF in both FA and SS groups was similar (6–8 ± 2.6 × 104); however, after A. fumigatus challenge (+), the number of cells in FA/FA+ and FA/SS+ increased to 51–54 ± 8.3 × 104. The number increased to 92–98 ± 12.8 × 104 in SS/FA+ and SS/SS+ animals. Thus, A. fumigatus promoted leukocytic infiltration in the lungs, and the infiltration was significantly more pronounced in the animals exposed to SS prenatally; postnatal SS did not result in a significant difference in the total number of cells in the BALF (Table I).

View this table:
  • View inline
  • View popup
Table I. Leukocytic composition of BALF cells

The differential BALF cell count (Table I) indicated that macrophages were the predominant cell population in the BALF from FA/FA, FA/FA+, and FA/SS+, accounting for 90.8 ± 4.4, 95 ± 1.6, and 92.1 ± 2.6%, respectively. Thus, although the A. fumigatus challenge strongly increased the total number of BALF cells, the percentages of macrophages did not vary significantly among the groups; nonetheless, animals exposed postnatally to SS (FA/SS) had small, but significantly higher, numbers of neutrophils. In contrast, prenatally SS-exposed groups (SS/FA and SS/SS) showed a dramatic decrease in the proportion of macrophages, with concomitant increases in neutrophils and eosinophils. These results suggested that prenatal exposure strongly primes the lung for neutrophilic and eosinophilic inflammation.

Prenatal SS increases total serum IgE levels

Atopy is a strong risk factor for allergic asthma in children (32). To ascertain whether prenatal and/or postnatal SS exposure affects atopy differentially, we measured the serum levels of IgE in the four groups of mice after A. fumigatus sensitization. Results (Fig. 1E) indicated that compared with FA/FA, prenatal (SS/FA) and early postnatal (FA/SS) exposure independently elevated total serum IgE levels; however, the IgE level in SS/FA (prenatally SS-exposed animals) of 29.50 ± 14.41 μg/ml was significantly higher than the IgE level of 8.81 ± 2.49 μg/ml in FA/SS (SS exposure only during the early postnatal period). Although, the mean IgE concentration of 39.83 ± 2.75 μg/ml in SS/SS (prenatally and postnatally SS exposure) was higher than in prenatally SS-exposed animals, it did not reach statistical significance. These results suggested that although prenatal and early postnatal exposure is independent risk factors for atopy, prenatal exposure is a substantially stronger risk factor.

Prenatal SS activates GATA3, ERK1/2, LCK, and STAT6

Th2 cytokines are intimately associated with allergic asthma, and coincident with Th2 development is activation of the IL-4/STAT6 pathway that enhances the expression of GATA3 (33). GATA3 is the master transcription factor for Th2 differentiation and, under physiological conditions, it is selectively expressed in Th2 but not Th1 cells and induces Th2 cytokine gene expression (33, 34). Lck, ERK, and STAT6 regulate GATA3 activity (34–36). Therefore, we examined the lung expression of GATA3, Lck, ERK, and STAT6 by quantitative PCR and/or WB analysis. Fig. 2A shows a representative response of various groups of SS-exposed mice. Mice exposed gestationally to SS (SS/FA and SS/SS) and subsequently exposed to A. fumigatus exhibited significantly higher levels of activated (phosphorylated) GATA3. Increased GATA3 expression in prenatally SS-exposed animals was also seen by quantitative PCR analysis (Fig. 2B). Moreover, prenatal, but not postnatal, exposure to SS activated phosphorylated ERK1/2; total ERK1/2 was not affected by either pre- or postnatal SS (Fig. 2C). Similarly, prenatal, but not postnatal SS, increased activation (phosphorylation) of Lck (Fig. 3A) and STAT6 (Fig. 3B); neither pre- nor postnatal SS affected the expression of actin (Fig. 3C). These results suggested that prenatal, but not postnatal, SS activates the Th2-signaling pathway (GATA3/Lck/ERK/STAT6). A. fumigatus sensitization is critical for the visualization of SS-induced exaggerated Th2 and AHR responses; without A. fumigatus sensitization, the baseline phosphorylation of GATA3/STAT6 (Supplemental Fig. 3) and Lck/ERK1/2 (data not shown) was comparable between various groups. Thus, activation of GATA3/Lck/ERK/STAT6 is associated with an exacerbated allergen-induced asthmatic phenotype following gestational exposure to SS.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Prenatal SS exposure induces GATA3 and ERK activation. A, Left panel, Representative result of WB analysis of lung homogenate (70 μg protein) probed with anti–phospho-GATA3 Ab. Right panel, Densitometry analysis of blots from three separate experiments. B, Lung GATA3 mRNA expression by quantitative PCR, as described in Materials and Methods (n = 5/group). C, Left panel, Representative result of three WB analyses of lung homogenates probed with phosphorylated (p)-ERK1/2 Ab and total ERK1/2. Right panel, Densitometry analysis of blots from three separate experiments. Bars represent the mean ± SD. *p ≤ 0.05, ***p ≤ 0.001.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Prenatal SS activates Lck and STAT6. Lung homogenates (70 μg) were analyzed by WB. A, The blots were probed with anti phospho (p)-Lck Ab. Right panel, Densitometry analysis of blots from three separate experiments. B, The blots were probed with anti p-STAT6 Ab. Right panel, Densitometry analysis of blots from three separate experiments. C, The blots were probed with anti–β-actin Ab. The figures are representative of three separate analyses. Bars represent the mean ± SD. ***p ≤ 0.001.

Prenatal SS does not affect allergen-induced NF-κB and STAT5 activation

NF-κB, a ubiquitously expressed transcription factor plays a vital role in inflammatory responses and is activated in some chronic lung diseases, such as COPD (37). NF-κB has also been implicated in IL-13–induced lung pathology (38). Serine phosphorylation of NF-κB–p65 subunit was shown to be important in the function of NF-κB as a transcription factor (39); therefore, we determined the level of phosphorylated NF-κB–p65 in the lung extracts as an index of NF-κB activation. As seen in Fig. 4A, although allergic sensitization increased phosphorylated NF-κB–p65, neither prenatal nor postnatal SS exposure significantly affected the magnitude of this activation; therefore, it is unlikely that exacerbated allergic asthma associated with prenatal SS exposure is linked to activation of NF-κB. Early production of the Th2 cytokine IL-4 is regulated by phosphorylation of the transcription factor STAT5 (40); however, results presented in Fig. 4B showed that neither pre- nor postnatal SS significantly altered activation (phosphorylation) of STAT5. Together, these results suggested that NF-κB and STAT5 are not strongly associated with the SS-induced exacerbated Th2 responses. Prenatal and early postnatal SS exposure strongly suppresses the allergen-induced T-bet expression in the lung GATA3 and T-bet are two opposing transcription factors for Th1 and Th2 development, respectively (40, 41). Results (Fig. 5) clearly showed that sensitization of control (FA/FA) animals with A. fumigatus (FA/FA+) strongly increased the level of T-bet in the lung; however, animals exposed to SS either prenatally (SS/FA) or postnatally (FA/SS) exhibited a dramatic reduction in the A. fumigatus-induced T-bet protein levels (Fig. 5A). WB data presented in Supplemental Fig. 3 (top panel) show that exposure to an allergen is essential to upregulate T-bet expression. Quantitative PCR data indicating that prenatal and early postnatal exposure to SS downregulated the expression of T-bet mRNA (Fig. 5B) also supported these results. Thus, prenatal and early postnatal exposure to SS suppresses the allergen-induced T-bet expression, which might impair the development of Th1 responses in the lung. To evaluate the effect of SS exposure on the prototype Th1 cytokine, IFN-γ levels were assayed in the BALF of the experimental animals. Although the various groups did not exhibit significant differences in the basal (nonsensitized) levels of IFN-γ (Supplemental Fig. 2C), FA/FA animals exhibited a significant increase in the BALF levels of IFN-γ after A. fumigatus sensitization. In contrast, the IFN-γ levels in animals exposed either prenatally and/or postnatally to SS failed to upregulate the BALF levels of IFN-γ after the A. fumigatus challenge (Fig. 5C). Thus, SS exposure affected T-bet and IFN-γ similarly.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

SS does not affect NF-κB or STAT5 activation. Lung homogenates (75 μg protein) were analyzed by WB, and the blots were probed with anti–phosphorylated-p65 Ab (A) or anti–phosphorylated-STAT5 Ab (B). Data are representative of three separate sets of analyses. A and B, Right panels, Densitometry analysis of blots from three separate experiments. Bars represent the mean ± SD. ***p ≤ 0.001.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Prenatal and/or postnatal SS suppresses T-bet and IFN-γ. A, Representative results of lung homogenates (75 μg protein) analysis by WB, and probed with anti–T-bet Ab. Right panel, Densitometry analysis of blots from three independent experiments. B, T-bet mRNA expression in the lung tissue analyzed by quantitative PCR, as described in Materials and Methods. C, IFN-γ level in BALF, as described in Materials and Methods. (n = 5/group.) Bars represent the mean ± SD. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.

Prenatal and/or early postnatal exposure to SS suppresses mucus formation and expression of Muc5ac and GABAARs in the lung

Mucus produced by mucosal epithelial cells in the respiratory tract acts as the first line of defense against inhaled pathogens, which are cleared by the mucociliary apparatus (42, 43). However, dysregulated mucus formation is an important factor in many lung diseases, including asthma. Recent evidence suggests that GABAARs and IL-13 are intimately associated with the airway mucin Muc5ac and mucus formation by bronchial epithelial cells (44, 45). To ascertain the effects of prenatal and postnatal SS exposure on mucus formation, we determined the expression of Muc5ac (Fig. 6A) and GABAARs (Fig. 6B) by quantitative PCR and WB analysis, respectively, as well as the presence of mucus in the lung (Fig. 7) by immunohistochemistry. As expected, in control (FA/FA) animals, A. fumigatus sensitization led to significant increases in the airway mucus content (Fig. 7A, 7B). Surprisingly, however, the amount of mucus was dramatically reduced in the airways during early postnatal (Fig. 7D), prenatal (Fig. 7C), and prenatal plus postnatal (Fig. 7E) SS exposure. The histopathologic data were validated by determining the Vs of mucosubstances in the mucosal surface epithelium of the lung airways (Fig. 7F). These results were further supported by the observation that prenatal and postnatal SS exposure independently decreased the expression of Muc5ac (Fig. 6A) and GABAARs (Fig. 6B) in the lung. Without allergic (A. fumigatus) challenge, GABAAR expression is similar in all groups (Supplemental Fig. 3, panel 4). Thus, prenatal and/or early postnatal SS exposure suppresses mucus production that might adversely impact the mucociliary clearance and defense against inhaled pathogens/noxious particulate agents in these animals.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

SS exposure suppresses Muc5ac and GABAAR expression. A, Muc5ac mRNA expression in the lung tissue analyzed by quantitative PCR (n = 5/group). B, Representative result of three independent WB analyses of lung homogenate (75 μg protein) probed with anti-GABAAR Ab. Right panel, Densitometry analysis of blots from three separate experiments. Bars represent the mean ± SD. ***p ≤ 0.001.

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

SS exposure suppresses the allergen-induced airway mucus and SPDEF formation. Lung sections (5 μm) were stained with AB-PAS for mucus and SPDEF, as described in the Materials and Methods. Representative histologic photomicrographs (40×) of the lung sections show the mucus-producing cells in pink and SPDEF in brown. Mucus staining: FA/FA (A), FA/FA+ (B), FA/SS+ (C), SS/FA+ (D), and SS/SS+ (E). F, Volume density (Vs) of AB-PAS–stained mucosubstances in the mucosal surface in the lung epithelium (n = 5/group). Bars represent the mean ± SD. ***p ≤ 0.001. SPDEF staining: FA/FA (G); FA/FA+ (H), and SS/FA+ (I) (n = 3/group).

Prenatal exposure to SS suppresses SPDEF expression in the lung airways

SPDEF is the transcription factor that plays an important role in the development and differentiation of pulmonary goblet cell and mucus production (46). Because SPDEF is primarily restricted to goblet cells, we ascertained the expression of SPDEF in airway epithelial cells by immunohistochemistry. Results presented in Fig 7. show that SPDEF is expressed moderately in nonsensitized FA/FA airways (Fig. 7G); upon sensitization with A. fumigatus, FA/FA animals strongly upregulated the expression of SPDEF (Fig. 7H). However, A. fumigatus sensitization of prenatally SS-exposed animals (SS/FA) failed to increase the expression of SPDEF in the airways; indeed, the expression of SPDEF in SS/FA animals (Fig. 7I) was even lower than the basal levels in control FA/FA animals. Drastic reduction in SPDEF levels was also seen in FA/SS animals (data not shown). Thus, the inability of allergens to upregulate the expression of SPDEF in prenatally and/or early postnatally SS-exposed animals may be the main cause for impaired differentiation of goblet cells and mucus production in these animals.

Discussion

Th2 bias, atopy, and AHR are the hallmarks of allergic asthma (3–5, 47) and, in animal models, prenatal plus perinatal exposure to mainstream or secondhand cigarette smoke increases AHR and Th2 lung inflammation (25); however, AHR and Th2 polarization do not overlap mechanistically (5). Therefore, it is possible that prenatal and perinatal exposure to cigarette smoke affect AHR and Th2 lung inflammation differentially. In this article, we showed that gestational, but not early postnatal, exposure to SS primes the lung to dramatic increases in allergen-induced airway resistance (RL) as well as Th2 inflammation (increased IL-4 and IL-13 levels) and increased levels of serum IgE. Although the allergen sensitization of gestationally SS-exposed animal caused a significant increase in the serum IgE levels, the IgE may or may not be specific to the allergen. A mild increase in AHR has been reported after early postnatal exposure to SS (48), these studies used Penh values to quantitate AHR. However, the value of Penh in determining lung function and airway resistance has been strongly challenged (49, 50). Therefore, there is no tangible evidence that early postnatal exposure to SS increases airway resistance significantly.

The mechanism by which cigarette smoke exacerbates Th2 responses is largely unknown. Activation of GATA3 is intimately associated with Th2 polarization and suppression of Th1 responses; on the contrary, T-bet promotes Th1 and suppresses Th2 polarization (51–54). We observed that although A. fumigatus sensitization in normal (FA/FA) animals resulted in an upregulated expression of both GATA3 and T-bet, mice exposed prenatally to SS exhibited a strong upregulated expression of GATA3 and a dramatic suppression of T-bet, indicating while gestational SS promotes Th2 polarization, it simultaneously downregulates Th1 activation. Effects of SS exposure on the Th1 cytokine IFN-γ were similar to those seen with T-bet; thus, exposure to SS causes parallel changes in T-bet and IFN-γ. Although prenatal and/or early postnatal exposure to SS suppressed T-bet, effects of early postnatal SS on GATA3 expression were only weakly higher than control. Thus, although both prenatal and early postnatal SS exposure downregulate T-bet and IFN-γ, increased GATA3 expression is primarily associated with prenatal SS exposure. GATA3 is known to decrease T-bet expression (54); however, it is not clear whether GATA3 is the only factor that downregulates T-bet in gestationally SS-exposed animals. Nonetheless, given that Th1 responses are important in clearing infections, decreased T-bet could increase the risk for protracted lung infections and, at least in part, explain the increased risk for infections among children exposed to cigarette smoke through parental smoking (55–57).

Among the factors that promote Th2 development is the IL-4–STAT6 pathway that enhances the expression of GATA3 and Th2 polarization (34). Although STAT5 has also been implicated in Th2 responses, this transcription factor primarily affects the early IL-4 production (40), and the A. fumigatus-induced activation STAT5 was not significantly affected by either prenatal or postnatal SS exposures. In contrast, although prenatal exposure strongly activated STAT6, activation of STAT6 by postnatal SS was much weaker. Thus, activation of STAT6 may play a significant role in activation of GATA3 by prenatal SS exposure. In addition to STAT6, a number of other factors promote GATA3 activation during Th2 polarization. Lck controls GATA3 and IL-4 production, and Lck−/− Th2 cells have lower levels of IL-4 and GATA3 and a higher expression of T-bet and IFN-γ (36). Moreover, activated ERK inhibits ubiquitination and degradation of GATA3 in Th2 cells (35), thereby increasing the level of activated GATA3. In contrast, activated Lck and ERK negatively regulate T-bet expression (35, 36). Our results showed that Lck and ERK1/2 are activated in the lungs of prenatally SS-exposed animals, and these factors are likely to contribute to the increased GATA3 and decreased T-bet expression. The observation that early postnatal SS only weakly activated Lck/ERK1/2/GATA3 and Th2 polarization also supported a potential correlation between stronger upregulated activation of Lck/ERK1/2/GATA3 and stronger Th2 polarization in gestationally SS-exposed animals. However, although it is likely that STAT6 and Lck/ERK strongly trigger Th2 polarization in prenatally SS-exposed animals, other potential mechanisms of GATA3 activation contributing to Th2 polarization in these animals cannot be ruled out. For example, cigarette smoke was shown to elevate lung inflammation through epigenetic changes involving chromatin modifications (58), and proinflammatory cytokines, such as IL-6 (59, 60) also activate GATA3.

NF-κB is the transcription factor that regulates proinflammatory cytokine production, and it may play an important role in IL-13–induced lung pathogenesis (38). Activated NF-κB contains NF-κB–p50 and phosphorylated NF-κB–p65 subunits (61), and our results indicated that although A. fumigatus sensitization causes a sharp increase in p65, neither prenatal nor early postnatal SS significantly altered the magnitude of this response. Thus, although NF-κB might be important in allergic sensitization, it is unlikely to play a critical role in SS-induced exacerbated allergic asthma.

Direct methods, such as MCh or histamine, are commonly used to assess AHR; however, this approach has several drawbacks (62). It was observed that increased AHR detected by direct stimuli, such as histamine or MCh, is not specific to allergic asthma and may be associated with a number of other lung diseases, such as COPD, sarcoidosis, and bronchiectasis. Moreover, a significant number of normal subjects may also show increased AHR to these agents (reviewed in Ref. 63). In contrast, indirect stimuli (e.g., allergens) act on cell types, such as inflammatory and neuronal cells, to transmit the signal to effector cells and are considered a better indicator of asthma and inflammation (63). However, in general, allergen-specific AHR changes are much weaker than MCh-induced AHR changes and, therefore, are difficult to quantify. To our knowledge, allergen-induced AHR has not been reported in animal models, although the effects of allergens on isolated lungs and tracheal rings have been described (64, 65). Given the magnitude of MCh-induced RL in prenatally SS-exposed animals, we determined whether the prenatal SS exposure was a sufficiently strong trigger for a significant increase in allergen-induced RL. Indeed, prenatal, but not postnatal, SS exposure strongly increased the A. fumigatus-induced Rl, indicating that prenatal SS exposure is a strong stimulus for allergic asthma and an excellent animal model to test the efficacy of interventions for allergic asthma-associated AHR.

Mucus production is a cardinal feature of bronchial asthma and is associated with goblet cell metaplasia (66). IL-13 and IL-4 play a critical role in mucus formation (45, 67); however, despite large increases in Th2 cytokines, including IL-13/IL-4 in gestationally SS-exposed animals, prenatal and early postnatal SS exposure dramatically reduced airway mucus formation. Although IL-13 may induce lung inflammation and Muc5ac through the ERK1/2/MAPK pathway, independent of STAT6 (68, 69), STAT6 also controls Th2 cytokines and goblet cell metaplasia (70). Thus, despite the presence of IL-13 and activated STAT6 and ERK1/2, prenatal and early postnatal SS exposure suppresses goblet cell formation and mucus production. This observation was counterintuitive, because cigarette smoke is a strong promucus stimulus in humans and adult mice (71). Muc5ac is the major inducible mucin in the airways, its expression is controlled by GABAARs in airway epithelial cells (72), and the expression of both Muc5ac and GABAARs was strongly downregulated by pre- and/or early postnatal exposure to SS. Mammalian lung development starts in the fetus and continues for a significant period after birth (i.e., several weeks to several years in mice and humans, respectively) (73). It is possible that SS exposure during this critical period blocks or delays development of type II airway epithelial cells. The transcription factor SPDEF plays an important role in the growth and differentiation of goblet cells, and our results suggested that the lung expression of this critical transcription factor is downregulated by pre- and/or early postnatal SS exposure. Together, these results suggested that SS affects the differentiation of airway epithelial cells into goblet cells. Recently, Fu et al. (72) reported more GABAAR-expressing cells in the pulmonary neuroepithelial bodies from monkeys exposed gestationally to nicotine, suggesting an increased potential for mucus formation. A likely explanation for this is that cigarette smoke is a very complex mixture of thousands of chemicals, and some of these chemicals might affect early lung development/maturation. Prenatal and early postnatal exposure to SS might at least temporarily impair the developmental process and make cells either hypo- or hyperresponsive to various growth and differentiation factors. Indeed, prenatal nicotine was reported to adversely affect cellular communication and normal lung development (74), and early postnatal SS exposure impaired Clara cell secretory protein levels (15). We have some preliminary evidence that gestational exposure to SS affects lung development and the development of type II cells (S.P. Singh and M.L. Sopori, unpublished observations). Thus, prenatal and/or early postnatal SS exposure may impair/delay the development/differentiation of airway goblet cells and reduce mucus production, even in the presence of high levels of IL-13/IL-4 and activated STAT6 and ERK1/2.

The mucociliary apparatus is important in the clearance of pathogens from the respiratory tract, and mucosal epithelial cells act as the first line of defense against respiratory pathogens (42). Although excessive mucus production may contribute to the morbidity of some respiratory diseases, diminished mucus formation is likely to encourage respiratory infections. Together with suboptimal Th1 development through decreased T-bet, loss of mucus formation may increase the susceptibility and length of respiratory infections, as well as explain the increased risk for respiratory infections among children from mothers who smoke cigarettes. Overall, these studies strongly suggested that a fetus is exceptionally sensitive to cigarette smoke, which may promote the development of childhood allergic asthma and respiratory infections, and every effort should be made to dissuade women from being exposed to cigarette smoke, including environmental tobacco smoke, during pregnancy.

Disclosures

The authors have no financial conflicts of interest.

Acknowledgments

We thank Dr. John Routes (Medical College of Wisconsin, Milwaukee, WI) for generous supply of Aspergillus fumigatus extracts. We also thank Steve Randock and Wendy Piper for graphics and Paula Bradley for editorial help.

Footnotes

  • This work was supported in part by National Institutes of Health Grants RO1 DA017003 and R01 DA04208-17, Flight Attendant Medical Research Institute grants (to S.P.S. and N.C.M.), and funds from the Lovelace Respiratory Research Institute.

  • The online version of this article contains supplemental material.

  • Abbreviations used in this article:

    AB-PAS
    Alcian blue–periodic acid-Schiff
    AHR
    airways hyperreactivity
    BALF
    bronchoalveolar lavage fluid
    COPD
    chronic obstructive pulmonary disease
    FA
    filtered air
    GABAAR
    γ-aminobutyric acid A receptor
    i.t.
    intratracheally
    MCh
    methacholine
    RL
    airway resistance
    RT
    room temperature
    SPDEF
    SAM pointed domain-containing Ets-like factor
    SS
    secondhand cigarette smoke
    Vs
    volume density
    WB
    Western blot.

  • Received May 27, 2011.
  • Accepted August 20, 2011.
  • Copyright © 2011 by The American Association of Immunologists, Inc.

References

  1. ↵
    1. Humbert M.,
    2. G. Menz,
    3. S. Ying,
    4. C. J. Corrigan,
    5. D. S. Robinson,
    6. S. R. Durham,
    7. A. B. Kay
    . 1999. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol. Today 20: 528–533.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Lemanske R. F., Jr..,
    2. W. W. Busse
    . 2003. Asthma. J. Allergy Clin. Immunol. 111(2 Suppl.) S502–S519.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Holt P. G.,
    2. J. Rowe,
    3. M. Kusel,
    4. F. Parsons,
    5. E. M. Hollams,
    6. A. Bosco,
    7. K. McKenna,
    8. L. Subrata,
    9. N. de Klerk,
    10. M. Serralha,
    11. et al
    . 2010. Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J. Allergy Clin. Immunol. 125: 653–659, 659, e1–e659, e7.
    OpenUrlCrossRef
  4. ↵
    1. Cates E. C.,
    2. R. Fattouh,
    3. J. R. Johnson,
    4. A. Llop-Guevara,
    5. M. Jordana
    . 2007. Modeling responses to respiratory house dust mite exposure. Contrib. Microbiol. 14: 42–67.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Singh S. P.,
    2. N. C. Mishra,
    3. J. Rir-Sima-Ah,
    4. M. Campen,
    5. V. Kurup,
    6. S. Razani-Boroujerdi,
    7. M. L. Sopori
    . 2009. Maternal exposure to secondhand cigarette smoke primes the lung for induction of phosphodiesterase-4D5 isozyme and exacerbated Th2 responses: rolipram attenuates the airway hyperreactivity and muscarinic receptor expression but not lung inflammation and atopy. J. Immunol. 183: 2115–2121.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Sopori M.
    2002. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2: 372–377.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Henderson A. J.
    2008. The effects of tobacco smoke exposure on respiratory health in school-aged children. Paediatr. Respir. Rev. 9: 21–27, quiz 27–28.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Pinkerton K. E.,
    2. J. P. Joad
    . 2000. The mammalian respiratory system and critical windows of exposure for children's health. Environ. Health Perspect. 108 (Suppl. 3): 457–462.
    OpenUrlCrossRefPubMed
    1. Kumar R.
    2008. Prenatal factors and the development of asthma. Curr. Opin. Pediatr. 20: 682–687.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Perera F. W.,
    2. W. Y. Tang,
    3. J. Herbstman,
    4. D. Tang,
    5. L. Levin,
    6. R. Miller,
    7. S. M. Ho
    . 2009. Relation of DNA methylation of 5′-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS ONE 4: e4488–e4502.
    OpenUrlCrossRefPubMed
  10. ↵
    1. DiFranza J. R.,
    2. C. A. Aligne,
    3. M. Weitzman
    . 2004. Prenatal and postnatal environmental tobacco smoke exposure and children’s health. Pediatrics 113(4, Suppl.)1007–1015.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Cook D. G.,
    2. D. P. Strachan
    . 1999. Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 54: 357–366.
    OpenUrlAbstract/FREE Full Text
    1. Cheraghi M.,
    2. S. Salvi
    . 2009. Environmental tobacco smoke (ETS) and respiratory health in children. Eur. J. Pediatr. 168: 897–905.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Dharmage S. C.,
    2. B. Erbas,
    3. D. Jarvis,
    4. M. Wjst,
    5. C. Raherison,
    6. D. Norbäck,
    7. J. Heinrich,
    8. J. Sunyer,
    9. C. Svanes
    . 2009. Do childhood respiratory infections continue to influence adult respiratory morbidity? Eur. Respir. J. 33: 237–244.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Phaybouth V.,
    2. S. Z. Wang,
    3. J. A. Hutt,
    4. J. D. McDonald,
    5. K. S. Harrod,
    6. E. G. Barrett
    . 2006. Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L222–L231.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Keil T.,
    2. S. Lau,
    3. S. Roll,
    4. C. Grüber,
    5. R. Nickel,
    6. B. Niggemann,
    7. U. Wahn,
    8. S. N. Willich,
    9. M. Kulig
    . 2009. Maternal smoking increases risk of allergic sensitization and wheezing only in children with allergic predisposition: longitudinal analysis from birth to 10 years. Allergy 64: 445–451.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Tanaka K.,
    2. Y. Miyake,
    3. S. Sasaki,
    4. Y. Ohya,
    5. Y. Hirota,
    6. Osaka Maternal and Child Health Study Group
    . 2008. Maternal smoking and environmental tobacco smoke exposure and the risk of allergic diseases in Japanese infants: the Osaka Maternal and Child Health Study. J. Asthma 45: 833–838.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Gergen P. J.,
    2. J. A. Fowler,
    3. K. R. Maurer,
    4. W. W. Davis,
    5. M. D. Overpeck
    . 1998. The burden of environmental tobacco smoke exposure on the respiratory health of children 2 months through 5 years of age in the United States: Third National Health and Nutrition Examination Survey, 1988 to 1994. Pediatrics 101: E8.
    OpenUrlPubMed
  17. ↵
    1. Wang C.,
    2. M. T. Salam,
    3. T. Islam,
    4. M. Wenten,
    5. W. J. Gauderman,
    6. F. D. Gilliland
    . 2008. Effects of in utero and childhood tobacco smoke exposure and beta2-adrenergic receptor genotype on childhood asthma and wheezing. Pediatrics 122: e107–e114.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Hu F. B.,
    2. V. Persky,
    3. B. R. Flay,
    4. A. Zelli,
    5. J. Cooksey,
    6. J. Richardson
    . 1997. Prevalence of asthma and wheezing in public schoolchildren: association with maternal smoking during pregnancy. Ann. Allergy Asthma Immunol. 79: 80–84.
    OpenUrlPubMed
    1. Jedrychowski W.,
    2. E. Flak,
    3. E. Mróz
    . 1997. [Cigarette smoking by mothers during pregnancy and pulmonary function of their school age children]. Pneumonol. Alergol. Pol. 65: 605–610.
    OpenUrlPubMed
  19. ↵
    1. Xepapadaki P.,
    2. Y. Manios,
    3. T. Liarigkovinos,
    4. E. Grammatikaki,
    5. N. Douladiris,
    6. C. Kortsalioudaki,
    7. N. G. Papadopoulos
    . 2009. Association of passive exposure of pregnant women to environmental tobacco smoke with asthma symptoms in children. Pediatr. Allergy Immunol. 20: 423–429.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Kulig M.,
    2. W. Luck,
    3. S. Lau,
    4. B. Niggemann,
    5. R. Bergmann,
    6. U. Klettke,
    7. I. Guggenmoos-Holzmann,
    8. U. Wahn
    . 1999. Effect of pre- and postnatal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life. Multicenter Allergy Study Group, Germany. Allergy 54: 220–228.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Pattenden S.,
    2. T. Antova,
    3. M. Neuberger,
    4. B. Nikiforov,
    5. M. De Sario,
    6. L. Grize,
    7. J. Heinrich,
    8. F. Hruba,
    9. N. Janssen,
    10. H. Luttmann-Gibson,
    11. et al
    . 2006. Parental smoking and children’s respiratory health: independent effects of prenatal and postnatal exposure. Tob. Control 15: 294–301.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Singh S. P.,
    2. E. G. Barrett,
    3. R. Kalra,
    4. S. Razani-Boroujerdi,
    5. R. J. Langley,
    6. V. Kurup,
    7. Y. Tesfaigzi,
    8. M. L. Sopori
    . 2003. Prenatal cigarette smoke decreases lung cAMP and increases airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 168: 342–347.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Joad J. P.,
    2. P. A. Munch,
    3. J. M. Bric,
    4. S. J. Evans,
    5. K. E. Pinkerton,
    6. C. Y. Chen,
    7. A. C. Bonham
    . 2004. Passive smoke effects on cough and airways in young guinea pigs: role of brainstem substance P. Am. J. Respir. Crit. Care Med. 169: 499–504.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Shao M. X.,
    2. T. Nakanaga,
    3. J. A. Nadel
    . 2004. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L420–L427.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Mishra N. C.,
    2. J. Rir-Sima-Ah,
    3. R. J. Langley,
    4. S. P. Singh,
    5. J. C. Peña-Philippides,
    6. T. Koga,
    7. S. Razani-Boroujerdi,
    8. J. Hutt,
    9. M. Campen,
    10. K. C. Kim,
    11. et al
    . 2008. Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J. Immunol. 180: 7655–7663.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Churg A.,
    2. M. Cosio,
    3. J. L. Wright
    . 2008. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L612–L631.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Wills-Karp M.,
    2. J. Luyimbazi,
    3. X. Xu,
    4. B. Schofield,
    5. T. Y. Neben,
    6. C. L. Karp,
    7. D. D. Donaldson
    . 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258–2261.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Barnes P. J.
    2008. Role of GATA-3 in allergic diseases. Curr. Mol. Med. 8: 330–334.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Gelfand E. W.
    2009. Pediatric asthma: a different disease. Proc. Am. Thorac. Soc. 6: 278–282.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Zhang D. H.,
    2. L. Cohn,
    3. P. Ray,
    4. K. Bottomly,
    5. A. Ray
    . 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272: 21597–21603.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Zhu J.,
    2. B. Min,
    3. J. Hu-Li,
    4. C. J. Watson,
    5. A. Grinberg,
    6. Q. Wang,
    7. N. Killeen,
    8. J. F. Urban Jr..,
    9. L. Guo,
    10. W. E. Paul
    . 2004. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5: 1157–1165.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Yamashita M.,
    2. R. Shinnakasu,
    3. H. Asou,
    4. M. Kimura,
    5. A. Hasegawa,
    6. K. Hashimoto,
    7. N. Hatano,
    8. M. Ogata,
    9. T. Nakayama
    . 2005. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J. Biol. Chem. 280: 29409–29419.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Kemp K. L.,
    2. S. D. Levin,
    3. P. J. Bryce,
    4. P. L. Stein
    . 2010. Lck mediates Th2 differentiation through effects on T-bet and GATA-3. J. Immunol. 184: 4178–4184.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Murugan V.,
    2. M. J. Peck
    . 2009. Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease. Exp. Lung Res. 35: 439–485.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Chapoval S. P.,
    2. A. Al-Garawi,
    3. J. M. Lora,
    4. I. Strickland,
    5. B. Ma,
    6. P. J. Lee,
    7. R. J. Homer,
    8. S. Ghosh,
    9. A. J. Coyle,
    10. J. A. Elias
    . 2007. Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13. J. Immunol. 179: 7030–7041.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Sasaki C. Y.,
    2. T. J. Barberi,
    3. P. Ghosh,
    4. D. L. Longo
    . 2005. Phosphorylation of RelA/p65 on serine 536 defines an IkappaBalpha-independent NF-kappaB pathway. J. Biol. Chem. 280: 34538–34547.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Christodoulopoulos P.,
    2. L. Cameron,
    3. Y. Nakamura,
    4. C. Lemière,
    5. S. Muro,
    6. M. Dugas,
    7. L. P. Boulet,
    8. M. Laviolette,
    9. R. Olivenstein,
    10. Q. Hamid
    . 2001. TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J. Allergy Clin. Immunol. 107: 586–591.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Jenner R. G.,
    2. M. J. Townsend,
    3. I. Jackson,
    4. K. Sun,
    5. R. D. Bouwman,
    6. R. A. Young,
    7. L. H. Glimcher,
    8. G. M. Lord
    . 2009. The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc. Natl. Acad. Sci. USA 106: 17876–17881.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Rose M. C.,
    2. J. A. Voynow
    . 2006. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86: 245–278.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Evans C. M.,
    2. J. S. Koo
    . 2009. Airway mucus: the good, the bad, the sticky. Pharmacol. Ther. 121: 332–348.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Xiang Y. Y.,
    2. S. Wang,
    3. M. Liu,
    4. J. A. Hirota,
    5. J. Li,
    6. W. Ju,
    7. Y. Fan,
    8. M. M. Kelly,
    9. B. Ye,
    10. B. Orser,
    11. et al
    . 2007. A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat. Med. 13: 862–867.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Kuperman D. A.,
    2. R. P. Schleimer
    . 2008. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr. Mol. Med. 8: 384–392.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Chen G.,
    2. T. R. Korfhagen,
    3. Y. Xu,
    4. J. Kitzmiller,
    5. S. E. Wert,
    6. Y. Maeda,
    7. A. Gregorieff,
    8. H. Clevers,
    9. J. A. Whitsett
    . 2009. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J. Clin. Invest. 119: 2914–2924.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Van Schoor J.,
    2. G. F. Joos,
    3. R. A. Pauwels
    . 2000. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur. Respir. J. 16: 514–533.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Barrett E. G.,
    2. J. A. Wilder,
    3. T. H. March,
    4. T. Espindola,
    5. D. E. Bice
    . 2002. Cigarette smoke-induced airway hyperresponsiveness is not dependent on elevated immunoglobulin and eosinophilic inflammation in a mouse model of allergic airway disease. Am. J. Respir. Crit. Care Med. 165: 1410–1418.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Sly P. D.,
    2. D. J. Turner,
    3. R. A. Collins,
    4. Z. Hantos
    . 2005. Penh is not a validated technique for measuring airway function in mice. Am. J. Respir. Crit. Care Med. 172: 256.
    OpenUrlPubMed
  47. ↵
    1. Lundblad L. K.,
    2. C. G. Irvin,
    3. Z. Hantos,
    4. P. Sly,
    5. W. Mitzner,
    6. J. H. Bates
    . 2007. Penh is not a measure of airway resistance! Eur. Respir. J. 30: 805.
    OpenUrlFREE Full Text
  48. ↵
    1. Zhou M.,
    2. W. Ouyang
    . 2003. The function role of GATA-3 in Th1 and Th2 differentiation. Immunol. Res. 28: 25–37.
    OpenUrlCrossRefPubMed
    1. Hwang E. S.,
    2. S. J. Szabo,
    3. P. L. Schwartzberg,
    4. L. H. Glimcher
    . 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307: 430–433.
    OpenUrlAbstract/FREE Full Text
    1. Usui T.,
    2. J. C. Preiss,
    3. Y. Kanno,
    4. Z. J. Yao,
    5. J. H. Bream,
    6. J. J. O’Shea,
    7. W. Strober
    . 2006. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J. Exp. Med. 203: 755–766.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Zhu J.,
    2. H. Yamane,
    3. J. Cote-Sierra,
    4. L. Guo,
    5. W. E. Paul
    . 2006. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 16: 3–10.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Dybing E.,
    2. T. Sanner
    . 1999. Passive smoking, sudden infant death syndrome (SIDS) and childhood infections. Hum. Exp. Toxicol. 18: 202–205.
    OpenUrlAbstract/FREE Full Text
    1. Bradley J. P.,
    2. L. B. Bacharier,
    3. J. Bonfiglio,
    4. K. B. Schechtman,
    5. R. Strunk,
    6. G. Storch,
    7. M. Castro
    . 2005. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115: e7–e14.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Marseglia G. L.,
    2. M. A. Avanzini,
    3. S. Caimmi,
    4. D. Caimmi,
    5. A. Marseglia,
    6. C. Valsecchi,
    7. D. Poddighe,
    8. G. Ciprandi,
    9. F. Pagella,
    10. C. Klersy,
    11. A. M. Castellazzi
    . 2009. Passive exposure to smoke results in defective interferon-gamma production by adenoids in children with recurrent respiratory infections. J. Interferon Cytokine Res. 29: 427–432.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Rajendrasozhan S.,
    2. H. Yao,
    3. I. Rahman
    . 2009. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 6: 291–297.
    OpenUrlCrossRef
  53. ↵
    1. Levy D. E.,
    2. J. E. Darnell Jr..
    2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651–662.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Hodge D. R.,
    2. E. M. Hurt,
    3. W. L. Farrar
    . 2005. The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41: 2502–2512.
    OpenUrlCrossRefPubMed
  55. ↵
    1. Ahn K. S.,
    2. B. B. Aggarwal
    . 2005. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann. N. Y. Acad. Sci. 1056: 218–233.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Joos G. F.
    2003. Bronchial hyperresponsiveness: too complex to be useful? Curr. Opin. Pharmacol. 3: 233–238.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Rogers D. F.,
    2. B. J. O’Connor
    . 1993. Airway hyperresponsiveness: relation to asthma and inflammation? Thorax 48: 1095–1096.
    OpenUrlFREE Full Text
  58. ↵
    1. Larsen G. L.,
    2. H. Renz,
    3. J. E. Loader,
    4. K. L. Bradley,
    5. E. W. Gelfand
    . 1992. Airway response to electrical field stimulation in sensitized inbred mice. Passive transfer of increased responsiveness with peribronchial lymph nodes. J. Clin. Invest. 89: 747–752.
    OpenUrlCrossRefPubMed
  59. ↵
    1. Witzenrath M.,
    2. B. Ahrens,
    3. S. M. Kube,
    4. A. Braun,
    5. H. G. Hoymann,
    6. A. C. Hocke,
    7. S. Rosseau,
    8. N. Suttorp,
    9. E. Hamelmann,
    10. H. Schütte
    . 2006. Detection of allergen-induced airway hyperresponsiveness in isolated mouse lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L466–L472.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    1. Izuhara K.,
    2. S. Ohta,
    3. H. Shiraishi,
    4. S. Suzuki,
    5. K. Taniguchi,
    6. S. Toda,
    7. T. Tanabe,
    8. M. Yasuo,
    9. K. Kubo,
    10. T. Hoshino,
    11. H. Aizawa
    . 2009. The mechanism of mucus production in bronchial asthma. Curr. Med. Chem. 16: 2867–2875.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Zhu Z.,
    2. R. J. Homer,
    3. Z. Wang,
    4. Q. Chen,
    5. G. P. Geba,
    6. J. Wang,
    7. Y. Zhang,
    8. J. A. Elias
    . 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779–788.
    OpenUrlCrossRefPubMed
  62. ↵
    1. Lee P. J.,
    2. X. Zhang,
    3. P. Shan,
    4. B. Ma,
    5. C. G. Lee,
    6. R. J. Homer,
    7. Z. Zhu,
    8. M. Rincon,
    9. B. T. Mossman,
    10. J. A. Elias
    . 2006. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J. Clin. Invest. 116: 163–173.
    OpenUrlCrossRefPubMed
  63. ↵
    1. Kono Y.,
    2. T. Nishiuma,
    3. T. Okada,
    4. K. Kobayashi,
    5. Y. Funada,
    6. Y. Kotani,
    7. S. Jahangeer,
    8. S. Nakamura,
    9. Y. Nishimura
    . 2010. Sphingosine kinase 1 regulates mucin production via ERK phosphorylation. Pulm. Pharmacol. Ther. 23: 36–42.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Fritz D. K.,
    2. C. Kerr,
    3. R. Fattouh,
    4. A. Llop-Guevara,
    5. W. I. Khan,
    6. M. Jordana,
    7. C. D. Richards
    . 2011. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent. J. Immunol. 186: 1107–1118.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    1. Yu H.,
    2. Q. Li,
    3. V. P. Kolosov,
    4. J. M. Perelman,
    5. X. Zhou
    . 2011. Regulation of cigarette smoke-induced mucin expression by neuregulin1β/ErbB3 signalling in human airway epithelial cells. Basic Clin. Pharmacol. Toxicol. 109: 63–72.
    OpenUrlCrossRefPubMed
  66. ↵
    1. Fu X. W.,
    2. K. Wood,
    3. E. R. Spindel
    . 2011. Prenatal nicotine exposure increases GABA signaling and mucin expression in airway epithelium. Am. J. Respir. Cell Mol. Biol. 44: 222–229.
    OpenUrlCrossRefPubMed
  67. ↵
    1. Shi W.,
    2. S. Bellusci,
    3. D. Warburton
    . 2007. Lung development and adult lung diseases. Chest 132: 651–656.
    OpenUrlCrossRefPubMed
  68. ↵
    1. Rehan V. K.,
    2. K. Asotra,
    3. J. S. Torday
    . 2009. The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung 187: 281–289.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Immunology: 187 (9)
The Journal of Immunology
Vol. 187, Issue 9
1 Nov 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prenatal Secondhand Cigarette Smoke Promotes Th2 Polarization and Impairs Goblet Cell Differentiation and Airway Mucus Formation
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prenatal Secondhand Cigarette Smoke Promotes Th2 Polarization and Impairs Goblet Cell Differentiation and Airway Mucus Formation
Shashi P. Singh, Sravanthi Gundavarapu, Juan C. Peña-Philippides, Jules Rir-sima-ah, Neerad C. Mishra, Julie A. Wilder, Raymond J. Langley, Kevin R. Smith, Mohan L. Sopori
The Journal of Immunology November 1, 2011, 187 (9) 4542-4552; DOI: 10.4049/jimmunol.1101567

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prenatal Secondhand Cigarette Smoke Promotes Th2 Polarization and Impairs Goblet Cell Differentiation and Airway Mucus Formation
Shashi P. Singh, Sravanthi Gundavarapu, Juan C. Peña-Philippides, Jules Rir-sima-ah, Neerad C. Mishra, Julie A. Wilder, Raymond J. Langley, Kevin R. Smith, Mohan L. Sopori
The Journal of Immunology November 1, 2011, 187 (9) 4542-4552; DOI: 10.4049/jimmunol.1101567
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606